A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer
KIF20A (RAB6KIFL) belongs to the kinesin superfamily of motor proteins, which play critical roles in the trafficking of molecules and organelles during the growth of pancreatic cancer. Immunotherapy using a previously identified epitope peptide for KIF20A is expected to improve clinical outcomes. A...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Lippincott Williams & Wilkins
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3868021/ https://ncbi.nlm.nih.gov/pubmed/24316554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000012 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|